Top Sell
Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Glycomimetics Inc. | 5 | 3 | 0 | 3 | €0.25 | €7.35 | 2870.343% |
Akebia Therapeutics Inc. | 7 | 3 | 0 | 1 | €0.87 | €3.60 | 312.741% |
Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
Avinger Inc. | 2 | 4 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
Pacific Biosciences of California Inc. | 9 | 5 | 0 | 0 | €1.20 | €9.62 | 699.327% |
Cara Therapeutics Inc. | 11 | 6 | 0 | 5 | €0.25 | €4.61 | 1719.510% |
T2 Biosystems Inc. | 0 | 7 | 0 | 0 | €0.16 | - | - |
Minerva Neurosciences Inc. | 0 | 7 | 0 | 2 | €2.88 | - | - |
Organovo Holdings Inc. | 0 | 7 | 0 | 0 | €0.68 | - | - |
Gritstone Oncology Inc | 4 | 9 | 0 | 7 | €0.54 | €0.50 | -6.977% |
Bellicum Pharmaceuticals Inc. | 0 | 12 | 0 | 0 | €0.064 | - | - |
Sangamo Therapeutics Inc. | 12 | 13 | 0 | 1 | €0.30 | €3.63 | 1113.373% |
Trevena Inc. | 3 | 19 | 1 | 4 | €0.15 | €4.60 | 3027.551% |